AVITA Medical (RCEL) Liabilities and Shareholders Equity (2018 - 2025)

AVITA Medical (RCEL) has 8 years of Liabilities and Shareholders Equity data on file, last reported at $56.4 million in Q4 2025.

• For the quarter ending Q4 2025, Liabilities and Shareholders Equity fell 29.25% year-over-year to $56.4 million; the trailing twelve-month figure through Dec 2025 stood at $247.8 million (down 28.37% YoY), and the FY2025 full-year result was $56.4 million, down 29.25% from the prior year.
• Liabilities and Shareholders Equity for Q4 2025 stood at $56.4 million, down from $63.7 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $128.1 million in Q1 2021 and bottomed at $56.4 million in Q4 2025.
• The 5-year median for Liabilities and Shareholders Equity is $95.0 million (2023), against an average of $93.2 million.
• The widest annual swing landed in 2021, when Liabilities and Shareholders Equity soared 67.4%; it then sank 33.81% in 2025.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $116.0 million in 2021, then decreased by 15.3% to $98.3 million in 2022, then gained by 13.61% to $111.6 million in 2023, then retreated by 28.6% to $79.7 million in 2024, then retreated by 29.25% to $56.4 million in 2025.
• The last three Liabilities and Shareholders Equity figures came in at $56.4 million (Q4 2025), $63.7 million (Q3 2025), and $58.1 million (Q2 2025), per Business Quant data.

Peer Comparison